12:47 PM · 9 October 2024

Bayer drops 7% as Washington court will review another case alleging Monsanto products

Shares of top-German, pharmaceutical and chemical giant, Bayer AG (BAYN.DE) fell today the most since March, as Washington state court will review a case alleging potentially toxic chemicals from the Monsanto, Bayer unit (completed acquisition in 2018). In such case, three teachers claim that, Monsanto product caused brain injuries.

The court denied an application for a 'speedy' review of this case.  According to Bloomberg Intelligence report, Bayer’s exposure to the Roundup litigation (another Monsanto's product) could exceed the Bayer's almosta $16 billion reserve by around 5%. German company has more than 57k unfinished cases related to Roundup; still claiming that Roundup is totally safe. 

Bayer AG (BAYN.DE, D1 interval)

As we can see below, Bayer shares failed to break above resistance of the EMA200 (red line) and now are falling back to levels unseen since half-September.

 

Source: xStation5

16 October 2026, 12:42 PM

Market wrap: European indices rebound 🔼 Defence stocks on the rise

16 October 2026, 10:21 AM

TSMC in Talks with Elon Musk Over Terafab

15 October 2026, 7:11 PM

Daily summary 📈 Precious metals and stock indices rebound as Treasury yields fall

15 October 2026, 3:40 PM

US Open: Nasdaq 100 extends losses 🚩 AI stocks under pressure, CoreWeave falls 8%

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits